Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo

Prudence, Mitangala Ndeba; Tsongo, Edgar Musubao; Mbeva, Jean Bosco Kahindo; Edmond, Ntabe Namegabe; Bonane, Janvier Kubuya; Guy, Mutombo Ndongala; Cyrille, Ngadjo Lotsima; Martin, Mwamba Nkulimba; Noterman, Jean Pierre; Sébastien, Matata Ngilima; Kakuse, Kanane; Robert, Vutsopire Kipumo; Hyppolite, Sangala Kisako; Liliane, Bwiza; Alex, Feruzi Mega; Samuel, Kabongo Kapitao; Nathalie, Kapambalisa Mwenge-Syali; Charles, Bakangana; Jules, Kafitiye Ntambwe; Elisabeth, Kahindo Mathe; Raphael, Kabangwa Kakongo Senga; Porignon, Denis

[ Séroprévalence des anticorps anti-SARS-CoV-2 au sein du personnel hospitalier dans la province du Nord Kivu, République Démocratique du Congo ]

Volume 36, Issue 1, April 2022, Pages 67–77

Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo

BibTex | RIS | EndNote | RefWorks

@article{IJIAS-22-074-10,
author = {Mitangala Ndeba Prudence and Edgar Musubao Tsongo and Jean Bosco Kahindo Mbeva and Ntabe Namegabe Edmond and Janvier Kubuya Bonane and Mutombo Ndongala Guy and Ngadjo Lotsima Cyrille and Mwamba Nkulimba Martin and Jean Pierre Noterman and Matata Ngilima Sébastien and Kanane Kakuse and Vutsopire Kipumo Robert and Sangala Kisako Hyppolite and Bwiza Liliane and Feruzi Mega Alex and Kabongo Kapitao Samuel and Kapambalisa Mwenge-Syali Nathalie and Bakangana Charles and Kafitiye Ntambwe Jules and Kahindo Mathe Elisabeth and Kabangwa Kakongo Senga Raphael and Denis Porignon},
title = {{Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo}},
journal = {International Journal of Innovation and Applied Studies},
volume = {36},
year = {2022},
pages = {67--77},
issue = {1},
number = {1},
issn = {2028-9324},
url = {http://www.ijias.issr-journals.org/abstract.php?article=IJIAS-22-074-10},
abstract_html_url = {http://www.ijias.issr-journals.org/abstract.php?article=IJIAS-22-074-10},
pdf_url = {http://www.issr-journals.org/links/papers.php?journal=ijias&application=pdf&article=IJIAS-22-074-10},
document_type={Article},
source={www.issr-journals.org}
}

TY  - JOUR
ID  - 
TI  - Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo
AU  - Mitangala Ndeba Prudence
AU  - Edgar Musubao Tsongo
AU  - Jean Bosco Kahindo Mbeva
AU  - Ntabe Namegabe Edmond
AU  - Janvier Kubuya Bonane
AU  - Mutombo Ndongala Guy
AU  - Ngadjo Lotsima Cyrille
AU  - Mwamba Nkulimba Martin
AU  - Jean Pierre Noterman
AU  - Matata Ngilima Sébastien
AU  - Kanane Kakuse
AU  - Vutsopire Kipumo Robert
AU  - Sangala Kisako Hyppolite
AU  - Bwiza Liliane
AU  - Feruzi Mega Alex
AU  - Kabongo Kapitao Samuel
AU  - Kapambalisa Mwenge-Syali Nathalie
AU  - Bakangana Charles
AU  - Kafitiye Ntambwe Jules
AU  - Kahindo Mathe Elisabeth
AU  - Kabangwa Kakongo Senga Raphael
AU  - Denis Porignon
PY  - 2022
VL  - 36
IS  - 1
SP  - 67
EP  - 77
JO  - International Journal of Innovation and Applied Studies
T2  - International Journal of Innovation and Applied Studies
SN  - 20289324
UR  - http://www.ijias.issr-journals.org/abstract.php?article=IJIAS-22-074-10
AB  - A multicenter cross-sectional study was conducted, between May and July 2021 before any anti-Covid-19 vaccination program implementation, among 720 staff working in six hospitals in the province of North Kivu in the eastern Democratic Republic of Congo.The aim of the study was to determine the seroprevalence of anti-SARS-CoV-2 antibodies.Individual data on socio-demographic and professional parameters and wearing mask were collected on the basis of a standard form. A blood sample was taken for qualitative determination of anti-SARS-CoV-2 antibodies using immuno-chromatographic “Panbio COVID-19 IgG/IgM Device (25T)” kits.The overall IgG/IgM sero-prevalence was 32.9% (n = 720). This seroprevalence among hospital staff was not significantly associated with their age, gender, professional category, department to which they were assigned in the hospital, or location in a rural or urban setting of their hospitals, nor to the systematic wearing of masks.Among hospital staff who reported contact with a Covid-19 patient, seroprevalence was twice as high at service on the workplace 32.6% (n = 282) [(PR (95% CI)], [2.30 (1.46 – 2.95)] (p = 0.001).In conclusion, the anti-SARS-CoV-2 antibodies seropositivity level among service providers in hospitals in North Kivu province in Eastern DRC is high and that contamination seems more than half as frequent in a professional hospital environment as at the level of the family unit.
ER  -

TY  - JOUR
ID  - 
TI  - Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo
AU  - Mitangala Ndeba Prudence
AU  - Edgar Musubao Tsongo
AU  - Jean Bosco Kahindo Mbeva
AU  - Ntabe Namegabe Edmond
AU  - Janvier Kubuya Bonane
AU  - Mutombo Ndongala Guy
AU  - Ngadjo Lotsima Cyrille
AU  - Mwamba Nkulimba Martin
AU  - Jean Pierre Noterman
AU  - Matata Ngilima Sébastien
AU  - Kanane Kakuse
AU  - Vutsopire Kipumo Robert
AU  - Sangala Kisako Hyppolite
AU  - Bwiza Liliane
AU  - Feruzi Mega Alex
AU  - Kabongo Kapitao Samuel
AU  - Kapambalisa Mwenge-Syali Nathalie
AU  - Bakangana Charles
AU  - Kafitiye Ntambwe Jules
AU  - Kahindo Mathe Elisabeth
AU  - Kabangwa Kakongo Senga Raphael
AU  - Denis Porignon
PY  - 2022
VL  - 36
IS  - 1
SP  - 67
EP  - 77
JO  - International Journal of Innovation and Applied Studies
SN  - 20289324
AB  - 
A multicenter cross-sectional study was conducted, between May and July 2021 before any anti-Covid-19 vaccination program implementation, among 720 staff working in six hospitals in the province of North Kivu in the eastern Democratic Republic of Congo.The aim of the study was to determine the seroprevalence of anti-SARS-CoV-2 antibodies.Individual data on socio-demographic and professional parameters and wearing mask were collected on the basis of a standard form. A blood sample was taken for qualitative determination of anti-SARS-CoV-2 antibodies using immuno-chromatographic “Panbio COVID-19 IgG/IgM Device (25T)” kits.The overall IgG/IgM sero-prevalence was 32.9% (n = 720). This seroprevalence among hospital staff was not significantly associated with their age, gender, professional category, department to which they were assigned in the hospital, or location in a rural or urban setting of their hospitals, nor to the systematic wearing of masks.Among hospital staff who reported contact with a Covid-19 patient, seroprevalence was twice as high at service on the workplace 32.6% (n = 282) [(PR (95% CI)], [2.30 (1.46 – 2.95)] (p = 0.001).In conclusion, the anti-SARS-CoV-2 antibodies seropositivity level among service providers in hospitals in North Kivu province in Eastern DRC is high and that contamination seems more than half as frequent in a professional hospital environment as at the level of the family unit.
ER  -

RT Journal Article
ID IJIAS-22-074-10
A1 Mitangala Ndeba Prudence
A1 Edgar Musubao Tsongo
A1 Jean Bosco Kahindo Mbeva
A1 Ntabe Namegabe Edmond
A1 Janvier Kubuya Bonane
A1 Mutombo Ndongala Guy
A1 Ngadjo Lotsima Cyrille
A1 Mwamba Nkulimba Martin
A1 Jean Pierre Noterman
A1 Matata Ngilima Sébastien
A1 Kanane Kakuse
A1 Vutsopire Kipumo Robert
A1 Sangala Kisako Hyppolite
A1 Bwiza Liliane
A1 Feruzi Mega Alex
A1 Kabongo Kapitao Samuel
A1 Kapambalisa Mwenge-Syali Nathalie
A1 Bakangana Charles
A1 Kafitiye Ntambwe Jules
A1 Kahindo Mathe Elisabeth
A1 Kabangwa Kakongo Senga Raphael
A1 Denis Porignon
YR 2022
T1 Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo
JF International Journal of Innovation and Applied Studies

Download

Mitangala Ndeba Prudence¹, Edgar Musubao Tsongo², Jean Bosco Kahindo Mbeva³, Ntabe Namegabe Edmond⁴, Janvier Kubuya Bonane⁵, Mutombo Ndongala Guy⁶, Ngadjo Lotsima Cyrille⁷, Mwamba Nkulimba Martin⁸, Jean Pierre Noterman⁹, Matata Ngilima Sébastien¹⁰, Kanane Kakuse¹¹, Vutsopire Kipumo Robert¹², Sangala Kisako Hyppolite¹³, Bwiza Liliane¹⁴, Feruzi Mega Alex¹⁵, Kabongo Kapitao Samuel¹⁶, Kapambalisa Mwenge-Syali Nathalie¹⁷, Bakangana Charles¹⁸, Kafitiye Ntambwe Jules¹⁹, Kahindo Mathe Elisabeth²⁰, Kabangwa Kakongo Senga Raphael²¹, and Denis Porignon²²

¹ ULB Coopération, PADISS, Bureau de Goma, RD Congo
² ULB Coopération, PADISS, Bureau de Goma, Nord-Kivu, RD Congo
³ ULB Coopération, Padiss, Bureau du Nord Kivu, Goma, RD Congo
⁴ Université Libre des Pays des Grands Lacs (ULPGL), Goma, Nord Kivu, RD Congo
⁵ Division Provinciale de la Santé du Nord Kivu, Goma, RD Congo
⁶ Division Provinciale de la Santé, Goma, Nord Kivu, RD Congo
⁷ Division Provinciale de la Santé, Goma, Nord Kivu, RD Congo
⁸ ULB Coopération, Goma, Nord Kivu, RD Congo
⁹ ULB Coopération, Goma, Nord Kivu, RD Congo
¹⁰ Hopital Provincial du Nord Kivu, Goma, Nord Kivu, RD Congo
¹¹ Hopital Provincial du Nord Kivu, Goma, Nord Kivu, RD Congo
¹² Division Provinciale de la Santé, Goma, Nord Kivu, RD Congo
¹³ Division Provinciale de la Santé, Goma, Nord Kivu, RD Congo
¹⁴ Division Provinciale de la Santé, Goma, Nord Kivu, RD Congo
¹⁵ ULB Coopération, Goma, Nord Kivu, RD Congo
¹⁶ Hopital Général de Référence de Kyondo, Kyondo, Nord Kivu, RD Congo
¹⁷ Hopital Général de Référence de Kyondo, Kyondo, Nord Kivu, RD Congo
¹⁸ Hopital Général d Référence de Rutshuru, Rutshuru, Nord Kivu, RD Congo
¹⁹ Université Libre des Pays des Grands Lacs « ULPGL”, Goma, Nord Kivu, RD Congo
²⁰ Hopital Général de Référence de Musienene, Musienene, Nord Kivu, RD Congo
²¹ Université Officielle de Ruwenzori « UOR », Butembo, Nord Kivu, RD CONGO
²² Université de Liège (ULG), Liège, Belgium

Original language: French

Copyright © 2022 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

A multicenter cross-sectional study was conducted, between May and July 2021 before any anti-Covid-19 vaccination program implementation, among 720 staff working in six hospitals in the province of North Kivu in the eastern Democratic Republic of Congo.The aim of the study was to determine the seroprevalence of anti-SARS-CoV-2 antibodies.Individual data on socio-demographic and professional parameters and wearing mask were collected on the basis of a standard form. A blood sample was taken for qualitative determination of anti-SARS-CoV-2 antibodies using immuno-chromatographic “Panbio COVID-19 IgG/IgM Device (25T)” kits.The overall IgG/IgM sero-prevalence was 32.9% (n = 720). This seroprevalence among hospital staff was not significantly associated with their age, gender, professional category, department to which they were assigned in the hospital, or location in a rural or urban setting of their hospitals, nor to the systematic wearing of masks.Among hospital staff who reported contact with a Covid-19 patient, seroprevalence was twice as high at service on the workplace 32.6% (n = 282) [(PR (95% CI)], [2.30 (1.46 – 2.95)] (p = 0.001).In conclusion, the anti-SARS-CoV-2 antibodies seropositivity level among service providers in hospitals in North Kivu province in Eastern DRC is high and that contamination seems more than half as frequent in a professional hospital environment as at the level of the family unit.

Author Keywords: Seroprevalence, anti-SARS-CoV-2, antibodies, hospital staff, North Kivu, DR Congo.

Abstract: (french)

Une enquête transversale multicentrique a été menée, entre mai et juillet 2021 avant toute mise en œuvre du programme de vaccination anti-Covid-19, auprès de 720 personnels œuvrant dans six hôpitaux de la province du Nord Kivu dans la partie Est de la République Démocratique du Congo.L’objectif poursuivi était de déterminer la séroprévalence des anticorps anti-SARS-CoV-2.Les données individuelles sur les paramètres sociodémographiques, professionnels et le port du masque ont été recueillies sur base d’un formulaire standard. Un échantillon de sang était prélevé pour la recherche qualitative des anticorps anti-SARS-CoV-2 par la méthode immuno-chromatographique rapide en utilisant les kits « Panbio COVID-19 IgG/IgM Device (25T) ».La séroprévalence globale IgG/IgM était de 32,9% (n = 720). Cette séroprévalence parmi les personnels des hôpitaux n’était significativement associée ni à leur âge, ni à leur sexe, ni à leur catégorie professionnelle, ni à leur service d’affectation dans l’hôpital, ni à la localisation dans un milieu rural ou urbain de leurs hôpitaux, ni au port systématique de masque.Parmi les personnels des hôpitaux ayant signalé un contact avec un malade Covid-19, la séroprévalence était 2 fois plus élevée lorsque le contact était survenu au domicile 75,0% (n= 16) comparée à ceux dont le contact était déclaré au service sur le lieu de travail 32,6% (n = 282) [(RP (IC à 95%)], [2,30 (1,46 – 2,95)] (p = 0,001).En conclusion, le niveau de séropositivité des anticorps anti-SARS-CoV-2 parmi les prestataires des hôpitaux de la province du Nord Kivu en RDC est élevé et que la contamination semble plus de deux fois moins fréquente en milieu professionnel hospitalier qu’au niveau du noyau familial.

Author Keywords: Séroprévalence, anticorps, anti-SARS-CoV-2, personnel hospitalier, Nord Kivu, RD Congo.

How to Cite this Article

Mitangala Ndeba Prudence, Edgar Musubao Tsongo, Jean Bosco Kahindo Mbeva, Ntabe Namegabe Edmond, Janvier Kubuya Bonane, Mutombo Ndongala Guy, Ngadjo Lotsima Cyrille, Mwamba Nkulimba Martin, Jean Pierre Noterman, Matata Ngilima Sébastien, Kanane Kakuse, Vutsopire Kipumo Robert, Sangala Kisako Hyppolite, Bwiza Liliane, Feruzi Mega Alex, Kabongo Kapitao Samuel, Kapambalisa Mwenge-Syali Nathalie, Bakangana Charles, Kafitiye Ntambwe Jules, Kahindo Mathe Elisabeth, Kabangwa Kakongo Senga Raphael, and Denis Porignon, “Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo,” International Journal of Innovation and Applied Studies, vol. 36, no. 1, pp. 67–77, April 2022.

About IJIAS

News

Submission

Downloads

Archives

Custom Search

Contact

Connect with IJIAS

Seroprevalence of anti-SARS-CoV-2 antibodies among hospital staff in North Kivu province, Democratic Republic of Congo

Abstract

Abstract: (french)

How to Cite this Article